A research center operated by the Nova Scotia Health Authority is collaborating with the Canadian division of GE Healthcare in a partnership designed to develop new MRI software for diagnosing and treating diseases of the brain, liver, and prostate.
The health authority's Biomedical Translational Imaging Centre (BIOTIC) said the deal with GE Healthcare Canada builds on the acquisition of a GE 3-tesla MRI scanner by QEII Health Sciences Centre in Halifax, Nova Scotia. The goal of the partnership is to validate and commercialize software tools that could be added as features on GE MRI scanners.
The software includes technology for providing automated software tools for presurgical functional brain mapping, liver disease, and prostate cancer, the companies said.
